GENEVA, Oct. 30 -- KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY filed a patent application (KR2026/005112) for “CANCER IMMUNOTHERAPY COMPOSITION COMPRISING PHENYLKETONE GROUP-CONTAINING BENZOYLINDOLIZINE-BASED COMPOUND AS ACTIVE INGREDIENT”. With publication no. WO/2026/225809, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/437
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....